As chief medical officer for GlaxoSmithKline (GSK), Murray Stewart has global responsibility for patient well-being across the vaccines, pharmaceutical, and consumer business units. Previous roles with GSK since 2000 include associate director for clinical research and development, clinical head of the biopharmaceuticals unit, and head of the cardiovascular and metabolic therapy. Before joining the pharmaceutical industry, Stewart worked as a diabetes consultant and senior lecturer and was consultant physician/honorary senior lecturer and head of clinical services at the Diabetes Centre, Newcastle upon Tyne in the United Kingdom. His research was in lipid metabolism in Type 2 diabetes. He did his medical training at Southampton Medical School and is a fellow of the Royal College of Physicians.

Healthcare Health,